Previous Article | Next Article ![]()
Journal of Clinical Microbiology, December 2001, p. 4523-4525, Vol. 39, No. 12
Section of Clinical Microbiology, Cleveland
Clinic Foundation, Cleveland, Ohio,1 and
Department of Clinical Microbiology, Mayo Clinic
Foundation, Rochester, Minnesota2
Received 27 June 2001/Returned for modification 7 August
2001/Accepted 17 September 2001
Detection of Giardia and
Cryptosporidium in clinical stool specimens using the
ColorPAC and ProSpecT enzyme immunoassays revealed 98.7% agreement for
Giardia detection and 98.1% agreement for Cryptosporidium detection. Sensitivities were uniformly
100%. The specificities of the ColorPAC immunoassay for
Giardia and Cryptosporidium detection
were 100 and 99.5%, respectively, and those for the ProSpecT assay
were 98.4 and 98.6%, respectively. The false-positive reactions with
the ProSpecT assay occurred with specimens that were grossly bloody.
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.12.4523-4525.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Evaluation of ColorPAC Giardia/Cryptosporidium
Rapid Assay and ProSpecT Giardia/Cryptosporidium
Microplate Assay for Detection of Giardia and
Cryptosporidium in Fecal Specimens
*
Corresponding author. Mailing address: Department of
Pathology, Mailstop L40, Cleveland Clinic Foundation, 9500 Euclid Ave., Cleveland, OH 44195. Phone: (216) 444-5879. Fax: (216) 445-6984. E-mail: procopg{at}ccf.org.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»